Newer synthetic progestins for the treatment of endometriosis.
D001777:Blood Coagulation; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D004064:Digestive System; D004194:Disease; D004617:Embolism; D004997:Ethinyl Estradiol; D005193:Family Planning Services; D006470:Hemorrhage; D007267:Injections; D008234:Lynestrenol; D017258:Medroxyprogesterone Acetate; D008597:Menstrual Cycle; D008598:Menstruation; D008656:Mestranol; D008796:Metrorrhagia; D009325:Nausea; D009640:Norethindrone; D009641:Norethynodrel; D011555:Pseudopregnancy; D012098:Reproduction; D012816:Signs and Symptoms; D013923:Thromboembolism; D014652:Vascular Diseases
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D004997:Ethinyl Estradiol; D009641:Norethynodrel; D008656:Mestranol; D017258:Medroxyprogesterone Acetate; D008234:Lynestrenol; D009640:Norethindrone
Bleeding; Blood Coagulation Effects; Contraception; Contraceptive Agents, Estrogen--therapeutic use; Contraceptive Agents, Female--therapeutic use; Contraceptive Agents, Progestin--therapeutic use; Contraceptive Agents--therapeutic use; Contraceptive Methods--contraindications; Contraceptive Methods--indications; Diseases; Embolism; Ethinyl Estradiol--therapeutic use; Family Planning; Gastrointestinal Effects; Injectables; Lynestrenol--therapeutic use; Medroxyprogesterone Acetate--therapeutic use; Menstrual Cycle; Menstruation; Mestranol--therapeutic use; Metrorrhagia; Nausea; Norethindrone Acetate--therapeutic use; Norethindrone--therapeutic use; Norethynodrel--therapeutic use; Oral Contraceptives, Combined; Oral Contraceptives--contraindications; Oral Contraceptives--indications; Pseudopregnancy; Reproduction; Signs And Symptoms; Thromboembolism; Vascular Diseases